Skip to main content

Table 1 Characteristics of the subjects with normal glucose tolerance (NGT) or diabetes mellitus (DM)

From: Adiponectin complexes composition in Japanese-Brazilians regarding their glucose tolerance status

 

NGT (n = 27)

DM (n = 26)

P value

Age (years)

54.0 ± 9.2

55.3 ± 8.6

0.58a

BMI(kg/m2)

23.4 ± 2.4

25.1 ± 2.4

0.015a

Waist circumference (cm)

79.4 ± 6.5

85.1 ± 7.6

0.005a

Waist-hip ratio

0.83 ± 0.05

0.88 ± 0.07

0.005a

Total cholesterol (mg/dL)

200.9 ± 39.3

209.7 ± 33.4

0.384a

HDL-Cholesterol (mg/dL)

48.8 ± 14.1

48.1 ± 8.4

0.809a

LDL-cholesterol (mg/dL)

121.7 ± 39.1

126.4 ± 33.3

0.638a

Triglycerides (mg/dL)

132.0 (97.2-171.5)

227.5 (160.0-380.0)

0.001b

Fasting plasma glucose (mg/dL)

104.0 (100.2-107.7)

134.5 (127.0-170.0)

<0.001b

Fasting plasma insulin (uU/mL)

5.8 ± 2.7

9.4 ± 3.3

<0.001a

HOMA-IR

1.39 (0.96-1.75)

3.01 (2.63-3.83)

<0.001b

eGFR (mL/min/1.73 m2)

98.1 ± 37.3

97.8 ± 32.8

0.97a

HbA1C (%)

-

6.2 (5.7-7.1)

-

Treatment for diabetes (n)

  

SU

-

2

-

MTF

-

1

-

SU + MTF

-

1

-

SU + INS

-

1

-

Treatment for hypertension (n)

  

B- blocker

1

-

-

Diuretic

1

1

-

ACEi

1

1

-

B-blocker + diuretic

1

1

-

Treatment for dyslipidemia (n)

  

fibrate

-

1

-

  1. Data are presented as mean ± SD, median (interquartile range) or n.
  2. SU: sulfonylrea; MTF: metformin; INS: insulin; ACEi: angiotensin-converting enzyme inhibitor;
  3. a t-test.
  4. b Mann–Whitney test.